To determine if the de novo expressed cell receptors after oncosuppressor mutation (Additional file 3: Table S3) and the newly identified cancer exosome ligands (Additional file 6: Table S6) played a role in the increased cancer exosomes uptake, displayed by BRCA1-KO fibroblasts, we used a panel of pharmacological antagonists. This evidence concerns the gene BRCA1 and cancer.